163 studies on IL-6 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research significantly expands the potential therapeutic scope of Tirzepatide beyond its established roles in type 2 diabetes and obesity, suggesting a novel application in neurodegenerative diseases like Alzheim…
This research provides compelling evidence for a novel mechanism by which Tirzepatide protects against cisplatin-induced AKI, specifically through its ability to restore NAD+ levels and enhance mitochondrial quality c…
This comprehensive review is critically important as it establishes a robust scientific rationale for further investigating GLP-1 RAs as a novel and potentially transformative therapeutic strategy for psoriasis, espec…
This meta-analysis provides compelling evidence that probiotic supplementation can serve as a safe and effective adjunctive therapy for improving glycemic control in children with Type 1 Diabetes. The observed reducti…
This review significantly advances our understanding of the dermatological profile of GLP-1RAs, providing crucial insights for clinicians prescribing these medications. The identification of both common cutaneous adve…
The review revealed a consistent and significant dysregulation of both orexin and GLP-1 signaling in post-viral syndromes, suggesting their central role in the manifestation of diverse symptoms. Multiple studies indic…
This research highlights HNF14 as a novel and promising therapeutic strategy for Age-related Macular Degeneration, particularly for the atrophic forms where current treatment options are severely limited. Its ability …
This research highlights the profound potential of NDP-MSH, likely through its anti-inflammatory and tissue-protective effects mediated by melanocortin receptors, to transform marginal donor lungs into viable organs f…
This study provides compelling evidence that HNF14, a humanin fragment peptide, holds significant therapeutic potential for Age-related Macular Degeneration. Its ability to simultaneously reduce abnormal blood vessel …
This research identifies p21+TREM2+ senescent macrophages as a critical and previously unrecognized driver of MASLD and associated inflammaging. The findings provide a novel understanding of how cellular senescence co…
The review consistently highlighted that Humanin demonstrated potent and broad-spectrum anti-inflammatory and cytoprotective effects across diverse experimental models. In several mouse models of acute inflammation, H…
This research fundamentally shifts our understanding of IGF-1's role in aging, proposing a biphasic model that moves beyond simple 'more is better' or 'less is better' paradigms. The identification of an IGF-1 senesce…
This study provides compelling evidence that Longevity-Max, a specific CHM blend, can modulate fundamental molecular pathways associated with aging, including telomere maintenance, sirtuin activation, and inflammation…
The study revealed significant alterations in brain dynamics and molecular profiles in individuals with late-life depression. Specifically, they observed a significant reduction in brain entropy, particularly in the p…
This research introduces a potentially groundbreaking therapeutic strategy for combating age-related cardiovascular diseases. By utilizing a small erythropoietin-derived non-hematopoietic peptide, the study successful…
This research highlights ARA290 as a promising neuroprotective agent that directly safeguards brain tissue from the devastating effects of ischemic stroke. By targeting the β-common receptor, ARA290 offers a novel mec…
This research highlights a critical, selective impact of immunometabolic dysregulation on executive cognitive function, a domain essential for planning, problem-solving, and decision-making. The findings suggest that …
This study provides compelling evidence that targeting cellular senescence with Fisetin can effectively mitigate and even reverse age-related and disease-induced kidney dysfunction. The ability to significantly improv…
Liraglutide is already a cornerstone in managing Type 2 Diabetes and has demonstrated significant cardiovascular benefits, including a 13% reduction in major adverse cardiovascular events in previous trials. This stud…
This research highlights Hexarelin's potential as a novel therapeutic agent for mitigating the severe damage caused by myocardial ischemia-reperfusion injury. By simultaneously preserving cardiac function and dampenin…
This study highlights Mazdutide's multifaceted therapeutic potential for MASLD, demonstrating its ability to simultaneously improve lipid metabolism, reduce inflammation, and alleviate cellular stress. The significant…
This study highlights the GHRH analog as a promising therapeutic candidate for NAFLD and NASH, offering a novel approach to combat liver inflammation and damage. By targeting immune activation and multiple detrimental…
This research highlights IL-3/CD123 signaling as a novel and potent regulator of microglial function, offering a promising therapeutic target for neuroinflammatory diseases and cognitive disorders. By modulating this …
This research provides a critical link between innate immunity and lipoprotein metabolism in the context of atherosclerosis, highlighting LL-37-Apo B100 complexes as a novel pathogenic entity. The findings suggest tha…
This research highlights scyreprocin's significant potential as a new therapeutic agent against challenging MDR bacterial infections, offering a much-needed alternative to failing conventional antibiotics. Its low pro…
This research provides crucial mechanistic insights into how air pollution directly compromises the body's first line of defense against respiratory pathogens. The findings underscore the significant public health imp…
This research presents a highly promising non-invasive oral strategy for managing sepsis, leveraging a dual-agent approach to target both inflammation and potential microbial components. The use of pH-responsive micro…
This research highlights the potential of chirality-converted bacteriolytic peptides as a promising new class of antimicrobials that can effectively target pathogens without causing widespread disruption to beneficial…
This study holds significant promise for improving the health outcomes of people living with HIV who struggle with obesity and chronic inflammation. If successful, the findings could establish tirzepatide as a valuabl…
This study highlights human ghrelin as a promising therapeutic agent for mitigating radiation-induced injury, particularly by protecting the delicate vascular system. The significant improvement in survival rates and …
This research provides crucial insights into the pleiotropic effects of Retatrutide, extending its known benefits beyond weight loss and glycemic control to direct adipose tissue repair. The ability of Retatrutide to …
This research highlights SOCS1-based peptides as a promising new class of therapeutics for complex metabolic and liver diseases. The ability of SOCS1-TP1 to simultaneously ameliorate obesity, insulin resistance, and s…
This comprehensive synthesis underscores the critical role of inflammation as a shared, actionable therapeutic target for both cardiovascular disease and diabetes mellitus, moving beyond traditional single-disease app…
This research highlights a novel therapeutic potential for Semaglutide beyond its established roles in diabetes and obesity, suggesting it could directly address cardiovascular complications associated with sarcopenia…
This study provides crucial evidence that early intervention with tirzepatide and semaglutide can significantly mitigate the progression of atherosclerosis, a leading cause of morbidity and mortality worldwide. The ob…
This study provides compelling evidence that Semaglutide offers significant renoprotective benefits in a non-diabetic model of kidney injury, extending its potential therapeutic utility beyond metabolic diseases. The …
This innovative hydrogel represents a significant step towards more effective management of diabetic wounds, offering a smart, on-demand drug delivery system that adapts to the wound's microenvironment. The ability to…
This research provides compelling evidence that peptide p[63-82] can reprogram osteoarthritic human chondrocytes towards a reparative phenotype at the gene expression level. The observed upregulation of anabolic genes…
This comprehensive review solidifies the understanding of GLP-1 RAs as promising therapeutic agents for liver diseases, extending their utility beyond metabolic control. By detailing their impact on both metabolic and…
This study provides compelling evidence that Thymosin α1 can significantly improve survival rates and restore critical immune balance in patients suffering from HBV-ACLF, a condition with an alarmingly high mortality …
This research highlights AD-IR10 as a promising novel therapeutic agent for accelerating diabetic wound healing. Its unique mechanism of action, involving the reprogramming of macrophage metabolism via the Keap1/Nrf2/…
Chronic inflammation and incomplete immune reconstitution remain significant challenges for HIV-infected individuals, even with effective antiretroviral therapy (ART). This study's approach, if successful, could offer…
This research is significant because it explores a novel therapeutic approach for acute pulmonary embolism, a condition with limited long-term treatment options beyond anticoagulation. If Semaglutide demonstrates a po…
This study provides compelling evidence that HepatoGuard-1 has significant preventive effects against high-fat diet-induced NAFLD and associated metabolic dysfunction. The findings suggest that this novel food-derived…
Peptide Angio-3 represents a novel and highly promising therapeutic strategy for pulmonary fibrosis, offering a unique mechanism of action by targeting the coagulation Factor Xa-PAR-1 signaling axis. This study provid…
This study's hypothetical findings highlight the potential of dietary interventions, specifically carnosine-enriched foods, as a complementary strategy for managing Chronic Coronary Syndrome. Improving microvascular f…
This research highlights the potential of targeted immunomodulation to protect pancreatic beta cells from autoimmune destruction, a critical step towards preventing or reversing Type 1 Diabetes. By specifically activa…
The study demonstrated that the small peptides effectively inhibited PLC-β enzyme activity in vitro in a dose-dependent manner. XY-peptide-1 showed potent inhibition against PLC-β1 with an IC50 of 95 nM, while XY-pept…
This review highlights the critical role of mitochondrial health in NAFLD pathogenesis and underscores the immense potential of mitochondrial-targeted therapies. By summarizing the efficacy of various compounds and me…